<p>GSK-3β and Bax were upregulated after the treatment of galectin-3 knockdown cells. The expression of the anti-apoptotic protein Bcl-2 was significantly reduced in galectin-3 knockdown cells. The simultaneous downregulation of pGSK-3β, β-catenin, c Myc, and the pro-apoptotic protein Bcl-2 was also found. </p
<p><u>Panel A.</u> Effect of enhanced GSK 3β activity on β-catenin integrity. 293 cells were transfe...
Background: The canonical Wnt signaling pathway has been considered as a potent oncogenic signaling ...
MYCN amplification occurs in about 20–25 % of human neuroblastomas and characterizes the majority of...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi (1 µ...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, transfection with a galect...
<p>The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi for 48 h on the...
<p>The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi for 48 h on cas...
<p>(<b>A</b>) Western blotting and (<b>B</b>) quantification results of Western blotting for galecti...
<p>Cells were treated with medium, Epi, and/or shGal-3 for 48 h. (<b>A</b>) Cell apoptosis was then ...
Background: Aberrant activation of the WNT/β-catenin and STAT3 signaling pathways plays a critical r...
We investigated the role of galectin-3 in tumor necrosis factor-related apoptosis-inducing ligand (T...
<p>LNCaP cells were treated with 6 μM or 9 μM of GSK-3 inhibitor (<i>A-C</i>); abl cells were treate...
HuR (ELAVL1), a RNA-binding protein, plays a key role in posttranscriptional regulation of multidrug...
<p><u>Panel A.</u> Effect of enhanced GSK 3β activity on β-catenin integrity. 293 cells were transfe...
Background: The canonical Wnt signaling pathway has been considered as a potent oncogenic signaling ...
MYCN amplification occurs in about 20–25 % of human neuroblastomas and characterizes the majority of...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi (1 µ...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, transfection with a galect...
<p>The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi for 48 h on the...
<p>The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi for 48 h on cas...
<p>(<b>A</b>) Western blotting and (<b>B</b>) quantification results of Western blotting for galecti...
<p>Cells were treated with medium, Epi, and/or shGal-3 for 48 h. (<b>A</b>) Cell apoptosis was then ...
Background: Aberrant activation of the WNT/β-catenin and STAT3 signaling pathways plays a critical r...
We investigated the role of galectin-3 in tumor necrosis factor-related apoptosis-inducing ligand (T...
<p>LNCaP cells were treated with 6 μM or 9 μM of GSK-3 inhibitor (<i>A-C</i>); abl cells were treate...
HuR (ELAVL1), a RNA-binding protein, plays a key role in posttranscriptional regulation of multidrug...
<p><u>Panel A.</u> Effect of enhanced GSK 3β activity on β-catenin integrity. 293 cells were transfe...
Background: The canonical Wnt signaling pathway has been considered as a potent oncogenic signaling ...
MYCN amplification occurs in about 20–25 % of human neuroblastomas and characterizes the majority of...